100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
440124-96-9Efavirenz Related Compound B
● In Stock
| Catalogue No.: | VL1680003 |
|---|---|
| CAS No.: | 440124-96-9 |
| Mol. Formula: | C14H11ClF3NO2 |
| Mol. Weight: | 317.69 g/mol |
Additional information on CAS 440124-96-9
Parent drug
EfavirenzIUPAC Name
(4S)-6-Chloro-4-[(1E)-2-cyclopropylethenyl]-1, 4-dihydro-4-(trifluoromethyl)-2H-3, 1-Benzoxazin-2-oneSynonyms
Efavirenz IP Impurity B / Efavirenz Ethene Analog / (E)-Dihydro EfavirenzDescription
Efavirenz Related Compound B or Efavirenz IP Impurity B / Efavirenz Ethene Analog / (E)-Dihydro Efavirenz (CAS No.(4S)-6-Chloro-4-[(1E)-2-cyclopropylethenyl]-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-Benzoxazin-2-one. Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that shows inhibitory action against HIV-1. It is a benzoxazinone and orally active compound.References
‘Adkins, Julie C., and Stuart Noble. “Efavirenz.†Drugs, vol. 56, no. 6, 1998, pp. 1055–64, https://doi.org/10.2165/00003495-199856060-00014. ?Kenedi, Christopher A., and Harold W. Goforth. “A Systematic Review of the Psychiatric Side-Effects of Efavirenz.†AIDS and Behavior, vol. 15, no. 8, Apr. 2011, pp. 1803–18, https://doi.org/10.1007/s10461-011-9939-5 ‘Request a Quote
"*" indicates required fields
Other products related to Efavirenz impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
Efavirenz
CAS No. 173676-54-5
Cat No. VE0022502
Efavirenz
CAS No. 205755-86-8 (Alternate CAS No. 1627575-36-3)
Cat No. VE0010511
